Pharmaceutical firm Lupin today reported a 39.50 per cent rise in its consolidated net profit at Rs 224.03 crore for the quarter ended December 31, 2010.
The company had posted a net profit of Rs 160.60 crore in the corresponding period previous fiscal, Lupin said in a filing to the Bombay Stock Exchange (BSE).
The consolidated total income during the third quarter of this fiscal also increased by 18.86 per cent to Rs 1,510.21 crore from Rs 1,270.58 crore in the year-ago period, it added.
However, the shares of the company were trading 3.81 per cent down at Rs 449.60 apiece on the BSE.
